Key insight: PD-L1, a molecular target of cancer immunotherapy, is so closely tied to pain in animal experiments, scientists think it may mean the more pain is felt, the better the treatment is working.


ain exists for a reason: It alerts us that something’s gone awry in our bodies. Now, a new study suggests that some cancers might block our ability to sense the pain that radiates from a tumor —allowing it to continue growing, surreptitiously.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Yep. As if people with cancer haven’t been manipulated, conned, and taken advantage of physically, emotionally and financially enough. Always another entity looking for what money you have left. Disgusting!

  • Since this is for subscription only readers, is there at least a reference to a journal article we can read for more information? Please!

  • Wow. Pretending to be an accessible article on the Globe main page and then demanding we subscribe to something completely separate from the Globe if we want to see it? Dirty trick.

  • Why masquerade as a Globe article and then not let people read the it? Hint: don’t go out of your way to look like you have your hand out for our hard earned dollars before you show you’re worth it. Right now, that would be a nope.

    • Trick articles are a good way to reduce STAT subscribers. I have to wade thru enough crap; not doing it here

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.